CommBank
CBA
Westpac Banking Corp
WBC
ANZ Group Holdings Ltd
ANZ
4
National Australia Bank Ltd
NAB
5
Telstra Group Ltd
TLS
AU Stock MarketDetailed Quotes
ALA Arovella Therapeutics Ltd
- 0.098
- 0.0000.00%
20min DelayMarket Closed Mar 20 15:48 AET
116.02MMarket Cap-10.89P/E (Static)
0.100High0.097Low1.47MVolume0.100Open0.098Pre Close145.49KTurnover0.21052wk High0.19%Turnover Ratio1.18BShares0.09152wk Low-0.006EPS TTM75.51MFloat Cap360.698Historical HighLossP/E (Static)770.51MShs Float0.020Historical Low-0.009EPS LYR3.06%Amplitude--Dividend TTM9.80P/B1Lot Size--Div YieldTTM
Arovella Therapeutics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 49.77%1.94M | 34.37%1.29M | -22.45%961.54K | -35.98%1.24M | 7.86%1.94M | -68.84%1.8M | -27.42%5.76M | 20.69%7.94M | 1.40%6.58M | -28.11%6.49M |
| Revenue from customers | ---- | -44.40%243.26K | 251.84%437.49K | -86.94%124.35K | -9.36%952.26K | -79.40%1.05M | -28.00%5.1M | 20.24%7.08M | -6.48%5.89M | -28.82%6.3M |
| Income from government grants | 84.51%1.94M | 100.13%1.05M | -53.02%524.04K | 13.31%1.12M | --984.54K | ---- | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | ---- | ---- | ---- | ---- | ---- | 12.39%745K | -22.62%662.88K | 24.58%856.66K | 265.20%687.63K | 8.08%188.29K |
| Cash paid | -16.74%-8.99M | -9.22%-7.7M | -48.18%-7.05M | 1.62%-4.76M | -18.73%-4.84M | 50.20%-4.07M | 5.65%-8.18M | -3.95%-8.67M | 14.35%-8.34M | 15.75%-9.73M |
| Payments to suppliers for goods and services | -16.74%-8.99M | -9.22%-7.7M | -48.18%-7.05M | 1.62%-4.76M | -18.73%-4.84M | 50.20%-4.07M | 5.65%-8.18M | -3.95%-8.67M | 14.35%-8.34M | 15.75%-9.73M |
| Direct interest paid | ---- | 88.81%-20.67K | -455.00%-184.78K | -82.71%-33.29K | -49.52%-18.22K | 90.93%-12.19K | 9.78%-134.43K | 1.56%-149K | -33.21%-151.37K | 14.02%-113.63K |
| Direct interest received | 362.27%138.77K | 680.75%30.02K | -34.45%3.85K | -82.25%5.87K | 10.23%33.05K | 1,085.61%29.98K | -89.34%2.53K | -78.36%23.73K | 6.69%109.65K | 109.19%102.77K |
| Operating cash flow | -8.07%-6.91M | -2.06%-6.4M | -76.84%-6.27M | -22.91%-3.54M | -27.65%-2.88M | 11.34%-2.26M | -198.29%-2.55M | 52.60%-854.22K | 44.70%-1.8M | -24.64%-3.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -287.96%-179.34K | 116.86%95.42K | -10.00%-566K | -32.47%-514.55K | 76.03%-388.42K | -339.62%-1.62M | 151.74%676.34K | 36.85%-1.31M | -62.64%-2.07M | 36.49%-1.27M |
| Net PPE purchase and sale | -235.55%-129.34K | 372.41%95.42K | 78.91%-35.03K | -17.73%-166.11K | 54.88%-141.09K | -357.81%-312.72K | 19.22%-68.31K | -216.44%-84.56K | 90.35%-26.72K | 3.96%-276.94K |
| Net intangibles purchas and sale | ---- | ---- | -52.38%-530.97K | -40.88%-348.45K | 81.09%-247.33K | -55.75%-1.31M | 31.32%-839.79K | 12.43%-1.22M | -40.21%-1.4M | 41.95%-995.82K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | --1.58M | ---- | ---- | ---- |
| Net investment purchase and sale | ---50K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---647.08K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -287.96%-179.34K | 116.86%95.42K | -10.00%-566K | -32.47%-514.55K | 76.03%-388.42K | -339.62%-1.62M | 151.74%676.34K | 36.85%-1.31M | -62.64%-2.07M | 36.49%-1.27M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 170.21%14.61M | -12.63%5.41M | -36.85%6.19M | 15,424.29%9.8M | -100.79%-63.94K | 3,947.62%8.1M | -86.51%200K | 2,048.55%1.48M | -98.98%69K | -13.41%6.79M |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | --0 | 175.86%200K | -30.95%72.5K | --105K | ---- |
| Net common stock issuance | 166.67%14.61M | -12.43%5.48M | -36.53%6.26M | --9.86M | ---- | --8.1M | ---- | 4,016.67%1.41M | -100.53%-36K | 14.27%6.79M |
| Net other financing activities | ---- | -5.30%-71.82K | -18.44%-68.2K | 9.95%-57.58K | ---63.94K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 170.21%14.61M | -12.63%5.41M | -36.85%6.19M | 15,424.29%9.8M | -100.79%-63.94K | 3,947.62%8.1M | -86.51%200K | 2,048.55%1.48M | -98.98%69K | -13.41%6.79M |
| Net cash flow | ||||||||||
| Beginning cash position | -14.75%5.18M | -9.62%6.07M | 587.20%6.72M | -77.34%977.47K | 4,295.99%4.31M | -94.46%98.13K | -27.73%1.77M | -60.83%2.45M | 56.67%6.25M | 430.20%3.99M |
| Current changes in cash | 939.20%7.52M | -38.59%-895.63K | -111.26%-646.23K | 272.05%5.74M | -179.14%-3.34M | 352.17%4.22M | -146.21%-1.67M | 82.15%-678.96K | -268.17%-3.8M | -29.90%2.26M |
| Effect of exchange rate changes | --22.95K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | 145.67%12.71M | -14.75%5.18M | -9.62%6.07M | 587.20%6.72M | -77.34%977.47K | 4,295.99%4.31M | -94.46%98.13K | -27.73%1.77M | -60.83%2.45M | 56.67%6.25M |
| Free cash from | -10.04%-7.04M | 6.35%-6.4M | -68.37%-6.83M | -24.05%-4.06M | 15.66%-3.27M | -12.26%-3.88M | -59.90%-3.46M | 33.43%-2.16M | 28.44%-3.25M | 1.76%-4.54M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |